Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomea Fusion Inc (BMEA)

Biomea Fusion Inc (BMEA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biomea Fusion Inc 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 USA

www.biomeafusion.com Employees: 106 P: 650-980-9099

Sector:

Medical

Description:

Biomea Fusion Inc. is a clinical-stage diabetes and obesity medicines company focused on the development of its oral small molecules, icovamenib and BMF-650. Biomea Fusion Inc., formerly known as BLOMEA FUSION, is based in Redwood City, California.

Key Statistics

Overview:

Market Capitalization, $K 88,670
Enterprise Value, $K 30,390
Shares Outstanding, K 37,572
Annual Sales, $ 0 K
Annual Net Income, $ -138,430 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -29,260 K
EBIT, $ -132,720 K
EBITDA, $ -130,970 K
60-Month Beta -0.23
% of Insider Shareholders 18.42%
% of Institutional Shareholders 96.72%
Float, K 30,651
% Float 81.58%
Short Volume Ratio 0.53

Growth:

1-Year Return -59.38%
3-Year Return -73.03%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.80 on 05/05/25
Next Earnings Date 07/30/25
Earnings Per Share ttm -3.55
EPS Growth vs. Prev Qtr 1.23%
EPS Growth vs. Prev Year 26.61%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BMEA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -197.71%
Return-on-Assets % -134.84%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.41
Book Value/Share 0.76
Interest Coverage -4.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar